Yuki Miyajima

Toyama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Nationwide surveillance of antibacterial susceptibility in bacterial respiratory pathogens in Japan, 2022-2023.

Nationwide surveillance of antibacterial susceptibility in bacterial respiratory pathogens in Japan, 2022-2023.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: May 18, 2025

Novel rapid method for identifying and quantifying pathogenic bacteria within four hours of blood collection.

Novel rapid method for identifying and quantifying pathogenic bacteria within four hours of blood collection.

Journal: Scientific reports

Published: July 27, 2023

Neutralizing Antibody Response of the Wild-Type/Omicron BA.1 Bivalent Vaccine as the Second Booster Dose against Omicron BA.2 and BA.5.

Neutralizing Antibody Response of the Wild-Type/Omicron BA.1 Bivalent Vaccine as the Second Booster Dose against Omicron BA.2 and BA.5.

Journal: Microbiology spectrum

Published: March 22, 2023

Comparative Study of Three Commercial Blood (1→3)-β-D-glucan Detection Reagents for Invasive Mycosis.

Comparative Study of Three Commercial Blood (1→3)-β-D-glucan Detection Reagents for Invasive Mycosis.

Journal: Medical mycology journal

Published: March 01, 2023

Predictive value of cell population data with Sysmex XN-series hematology analyzer for culture-proven bacteremia.

Predictive value of cell population data with Sysmex XN-series hematology analyzer for culture-proven bacteremia.

Journal: Frontiers in medicine

Published: February 02, 2023

Association of subpleural ground-glass opacities with respiratory failure and RNAemia in COVID-19.

Association of subpleural ground-glass opacities with respiratory failure and RNAemia in COVID-19.

Journal: European radiology

Published: July 21, 2022

Effect of Casirivimab/Imdevimab Treatment on Serum Type I Interferon Levels in SARS-CoV-2 Infection.

Effect of Casirivimab/Imdevimab Treatment on Serum Type I Interferon Levels in SARS-CoV-2 Infection.

Journal: Viruses

Published: May 30, 2022

Effectiveness of the third dose of BNT162b2 vaccine on neutralizing Omicron variant in the Japanese population.

Effectiveness of the third dose of BNT162b2 vaccine on neutralizing Omicron variant in the Japanese population.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: February 24, 2022

Circulating Type I Interferon Levels in the Early Phase of COVID-19 Are Associated With the Development of Respiratory Failure.

Circulating Type I Interferon Levels in the Early Phase of COVID-19 Are Associated With the Development of Respiratory Failure.

Journal: Frontiers in immunology

Published: December 27, 2021

Age-Dependent Reduction in Neutralization against Alpha and Beta Variants of BNT162b2 SARS-CoV-2 Vaccine-Induced Immunity.

Age-Dependent Reduction in Neutralization against Alpha and Beta Variants of BNT162b2 SARS-CoV-2 Vaccine-Induced Immunity.

Journal: Microbiology spectrum

Published: December 01, 2021

Correlation of the Commercial Anti-SARS-CoV-2 Receptor Binding Domain Antibody Test with the Chemiluminescent Reduction Neutralizing Test and Possible Detection of Antibodies to Emerging Variants.

Correlation of the Commercial Anti-SARS-CoV-2 Receptor Binding Domain Antibody Test with the Chemiluminescent Reduction Neutralizing Test and Possible Detection of Antibodies to Emerging Variants.

Journal: Microbiology spectrum

Published: December 01, 2021

SARS-CoV-2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID-19.

SARS-CoV-2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID-19.

Journal: Journal of medical virology

Published: August 02, 2021

Showing 1-12 of 24

Last Updated: 09/26/2026